Merck To Pay $100M To End NuvaRing Blood Clot Suits

By Kat Greene ( February 6, 2014, 10:08 PM EST) -- Merck & Co. has finalized an agreement to pay $100 million to settle all state and federal suits in the U. S. alleging its NuvaRing birth control causes fatal blood clots, the drug giant confirmed Friday. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login